Nattokinase Supplement Benefits: What the Research Says | Limits

Nattokinase may modestly lower blood pressure in some adults, but trials are small, doses vary, and it can raise bleeding risk with blood thinners.

The people most drawn to nattokinase often already take a blood thinner, which is exactly why the marketing deserves a second look. The enzyme forms when soybeans ferment into natto, and the case for nattokinase supplement benefits rests on small trials showing modest blood-pressure dips, not on proof it prevents heart attacks, strokes, or clots. Here is what the human data shows, where the evidence runs out, and which safety flags matter most for anyone on heart or stroke medication.

Does Nattokinase Actually Lower Blood Pressure?

Possibly, by a small amount. A 2023 systematic review and meta-analysis of six randomized controlled trials covering 546 participants concluded nattokinase may provide a modest blood-pressure benefit as an add-on, with no notable adverse events.

Two trials carry most of that conclusion. In one double-blind randomized trial, 86 adults with prehypertension or stage 1 hypertension took a single daily capsule of 2,000 fibrinolytic units (FU) for eight weeks; systolic and diastolic pressure both fell by week 8 but not by week 4. A separate double-blind, placebo-controlled multicenter trial of 79 healthy adults found diastolic pressure dropped after eight weeks at 100 mg a day (equivalent to 2,000 FU), while systolic pressure did not change. Lipid results were less encouraging: the review found relatively low doses did not significantly improve cholesterol or triglyceride profiles.

Nattokinase Supplement Benefits: Where The Evidence Stops

Past blood pressure, the claims outrun the data. Human studies have reported changes in factor VII, factor VIII, and fibrinogen after roughly two months of supplementation—surrogate lab markers that do not prove prevention of heart attacks, ischemic strokes, deep-vein thrombosis, or pulmonary embolism.

Evidence is also insufficient for lipid lowering as a primary goal, atherosclerosis prevention, detoxification, COVID-19 prevention, and reducing vaccine-related spike protein. As of 2024, no studies showed nattokinase prevents COVID-19 or lowers spike-protein concentrations in vaccinated people.

Dose, Product Labels, And Bleeding Risk

No clinical dose has been established, and potency varies by manufacturer, so the milligrams on the front of a bottle tell you little on their own. Clinical studies have used roughly 2,000 FU to 10,000 FU or more per day, and some ran two capsules of 2,000 FU each for two months. Labels often treat 100 mg as equivalent to 2,000 FU, but milligrams and FU are not interchangeable unless a manufacturer states the enzyme activity. A certificate of analysis matters more than the front panel, and a tested nattokinase supplement roundup compares products that publish their FU counts.

Bleeding is the risk that outweighs the rest. Nattokinase may raise bleeding risk through its fibrinolytic and antithrombotic effects, so Memorial Sloan Kettering’s nattokinase guidance advises against unsupervised use alongside warfarin, apixaban, rivaroxaban, dabigatran, heparin, clopidogrel, aspirin, or any other anticoagulant or antiplatelet medicine, and rules it out for people with coagulation disorders and anyone taking daily aspirin.

A published case report described an acute cerebellar hemorrhage in a patient taking nattokinase with aspirin. One case cannot establish cause, but it reinforces caution in anyone prone to bleeding. Products with residual vitamin K2 may also lower warfarin’s INR, so check labels for vitamin K content.

Skip nattokinase around surgery, after an ischemic stroke, with a history of peptic ulcer, during pregnancy or breastfeeding, and for children, where safety data are lacking. Stop and call a clinician for unusual bruising, nosebleeds, black stools, vomiting blood, or a severe headache.

Three checks before you buy:

• The FU count per serving is printed on the label, not just the milligrams.
• No anticoagulant, antiplatelet drug, or daily aspirin in your routine without a doctor’s approval.
• No recent surgery, ischemic stroke, or bleeding disorder in your history.